SI1251850T1 - Use of a combination preparation in cancer therapy - Google Patents

Use of a combination preparation in cancer therapy

Info

Publication number
SI1251850T1
SI1251850T1 SI200130571T SI200130571T SI1251850T1 SI 1251850 T1 SI1251850 T1 SI 1251850T1 SI 200130571 T SI200130571 T SI 200130571T SI 200130571 T SI200130571 T SI 200130571T SI 1251850 T1 SI1251850 T1 SI 1251850T1
Authority
SI
Slovenia
Prior art keywords
cancer therapy
combination preparation
preparation
combination
cancer
Prior art date
Application number
SI200130571T
Other languages
Slovenian (sl)
Inventor
Peter J Houghton
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Priority claimed from PCT/US2001/002372 external-priority patent/WO2001054678A2/en
Publication of SI1251850T1 publication Critical patent/SI1251850T1/en

Links

SI200130571T 2000-01-26 2001-01-24 Use of a combination preparation in cancer therapy SI1251850T1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US17854100P 2000-01-26 2000-01-26
PCT/US2001/002372 WO2001054678A2 (en) 2000-01-26 2001-01-24 Combination therapy for cancer
EP01908685A EP1251850B1 (en) 2000-01-26 2001-01-24 Use of a combination preparation in cancer therapy

Publications (1)

Publication Number Publication Date
SI1251850T1 true SI1251850T1 (en) 2006-10-31

Family

ID=37459649

Family Applications (1)

Application Number Title Priority Date Filing Date
SI200130571T SI1251850T1 (en) 2000-01-26 2001-01-24 Use of a combination preparation in cancer therapy

Country Status (1)

Country Link
SI (1) SI1251850T1 (en)

Similar Documents

Publication Publication Date Title
GB0016787D0 (en) Compounds useful in therapy
GB0028429D0 (en) Therapy
HUP0401903A3 (en) Improved use of et-743 in cancer thereapy
HUP0300005A3 (en) Modified cytokines for use in cancer therapy
GB0005257D0 (en) Breast cancer hormonal therapy
AU2002215111A1 (en) Ruthenium-aryl-compounds in cancer therapy
IL155509A0 (en) A combination comprising camptothecin and a stilbene derivative for the treatment of cancer
GB0018887D0 (en) Compound and their therapeutic use
SI1251850T1 (en) Use of a combination preparation in cancer therapy
GB2374018B (en) Ultrasound therapy
GB0017625D0 (en) Use of compounds in therapy
GB0030058D0 (en) Use of compounds in therapy
GB0012945D0 (en) Use of compounds in therapy
GB0014046D0 (en) Compounds useful in therapy
GB0015676D0 (en) Aryl compounds their preparation and their use in therapy
GB0022216D0 (en) Human FAP-a-specific antibodies for use in cancer therapy
GB0001926D0 (en) Biaryl compounds their preparation and their use in therapy
GB0130733D0 (en) Therapeutic compounds and their use in therapy
GB0018888D0 (en) Compounds and their therapeutic use
GB0018886D0 (en) Compounds and their therapeutic use
GB0018885D0 (en) Compounds and their therapeutic use
GB0025578D0 (en) Anthraquinone compounds their preparation and their use in therapy
GB0025581D0 (en) Flavan compounds, their preparation and their use in therapy
GB0004829D0 (en) New therapeutic use
GB0002217D0 (en) New therapeutic use